Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.26.1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 900,018 $ 941,760
Loans receivable, allowance for credit losses $ 70,468 $ 69,903
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 34,426,691 34,287,779
Common stock outstanding (shares) 29,806,694 29,894,757
Accumulated other comprehensive loss, tax benefit $ 18,717 $ 17,822
Treasury stock (shares) 4,619,997 4,393,022